Thousands of Americans campaigning for the Novavax COVID-19 booster got some good news this week: the FDA signaled it might ...

Buoyed by the breakthrough technologies and methodologies that have enabled earlier intervention, Alzheimer’s drug developers ...

Overall, Novo is expecting slower growth in 2025. The company is guiding for sales to rise between 16% and 24%, down from 26% ...

Novo Nordisk remains an industry leader, and currently offers both a 2.7% dividend yield and compelling value that can work ...

A March 11 email to FDA staff says the administration lowered government employee credit card limits to $1. Now to book ...

While JAZZ Pharmaceuticals JAZZ may not be a typical cannabis stock, it is the only company to market an FDA-approved drug ...

Many of the directions included in the order will be familiar to those who watched drug pricing policy closely during the ...

FDA Approves Losartan Oral Suspension Arbli Furoscix (furosemid injection) Loop diuretic Treatment of edema in patients with chronic kidney disease, including nephrotic syndrome. Wearable Furosemide ...

To get FDA approval, scientists must be able to demonstrate that a new drug or treatment is safe and effective. And currently, before they can test a new therapy in humans, they must show proof ...

The shares of Biocon Biologics Ltd were trading at ₹316.4 up by ₹10.15 or 3.31 per cent on the NSE today at 11 ... that the U.S. Food and Drug Administration has approved Jobevne (bevacizumab ...